By: Tracey O’Neal From: scnow.com Male breast cancer occurs when cancer cells form in the tissues of the breast. The disease is considered rare, with less than 1 percent of all breast cancers occurring in men. Additionally, the lifetime risk of being diagnosed with breast cancer for men is approximately 1 in 833, according to the American Cancer Society. Nationally, …
Life expectancy for stage 3 breast cancer
By: Tim Huzar From: medicalnewstoday.com Stage 3 breast cancer refers to cancer in the breast that has spread to several nearby lymph nodes. Doctors also describe breast cancer as stage 3 if a tumor is larger than 5 centimeters and cancer has spread to any lymph nodes, but not to distant organs. At stage 3, breast cancer may also spread …
Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses
Source: Novartis From: prnewswire.com – BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated HR+/HER2- advanced breast cancer after progression on an aromatase inhibitor or after receiving up to one additional line of therapy1 – SOLAR-1 is the first Phase III breast cancer trial to demonstrate potential viability of using liquid biopsy to select patients …
A new type of breast cancer treatment could help stop the spread of a highly aggressive form of the disease
By: Julia Naftulin From: thisisinsider.com Researchers from Princeton University discovered a new breast cancer treatment method that could stop the spread of an especially aggressive form of the disease called triple-negative breast cancer. The new method uses a naturally occurring protein called Tingal1 to block the passageways in which triple-negative breast cancer could spread to other areas of the body. …
Let Life Happen Celebrates 11 Years of Breast Cancer Support
View PostBreast cancer drugs could help treat therapy-resistant lung cancers
Source: PTI | London From: theweek.in A class of drugs used to treat certain breast cancers could help fight lung cancers A class of drugs used to treat certain breast cancers could help fight lung cancers that have become resistant to targeted therapies, according to a study conducted in mice. The study, published in the journal Cell Reports, found that …
What is the Cause of Breast Cancer? A New Paper in a Medical Journal Presents a Surprising Answer
From: PR Newswire Dr. Hanan Polansky from the CBCD published a new paper titled: “How latent viruses cause breast cancer: An explanation based on the microcompetition model.” The Center for the Biology of Chronic Disease (CBCD) announces the publication of a new paper [1] in the science journal ‘The Bosnian Journal of Basic Medical Sciences.’ The paper is important since it …
Lilly announces publication of analyses showing benefit of the addition of Verzenio® (abemaciclib) in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis
Source: PRNewswire From: biospace.com Subgroup analyses demonstrate consistent benefit in subgroups of patients with a more concerning prognosis such as those with liver metastases, PR-negative disease, high tumor grade, or shorter treatment-free interval Eli Lilly and Company (NYSE: LLY) today announced npj Breast Cancer published results from exploratory subgroup analyses of the MONARCH 2 and MONARCH 3 trials reinforcing the clinical …
The Responsibility of Doctors to Motivate Their Cancer Patients
View PostSermonix Reports FDA Acceptance of IND Application; Will Begin Phase 2 Trial of Lasofoxifene
From: streetinsider.com Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical company focused on the development and commercialization of female-specific oncology products, today announced that the U.S. Food and Drug Administration (FDA) accepted the company’s Investigational New Drug (IND) application, indicating that Sermonix may proceed directly to a Phase 2 clinical study in the personalized medicine arena involving its lead investigational drug, …